Important Information

AMP 2011 Annual Meeting CME Application Deadline
March 1, 2012
Visit the CME Application Page

AMP 2012 Annual Meeting on Genomic Medicine
October 25 - 27, 2012
Long Beach Convention & Entertainment Center
Long Beach, CA
Visit Meeting Page

AMP MGP Online Self-Study Review Course
Available September 1, 2011 - December 31, 2012
Visit the Course Page

Special Features

AMP International
AMP Test Directory
Awards, Grants & Honors
Career Development
Membership Information
Online Member Directory
The Journal of Molecular Diagnostics
Trainee Programs
Web Library

How to Help

Corporate Support Opportunities
Donate to AMP
Volunteer

News

AMP Mourns the Loss of Constance A. Griffin, MD

AMP mourns the loss of Constance (Connie) A. Griffin, MD, who passed away January 8, 2012 after a battle with pancreatic cancer. Connie was an oncologist, clinical cytogeneticist, researcher in pancreatic cancer and a long time AMP member and member of the Solid Tumors Subdivision. View the Baltimore Sun Notice. ...

U.S. Supreme Court Petitioned to Review AMP et al. Lawsuit on Gene Patents

December 2011: AMP is optimistic the Supreme Court will follow its precedents that render natural products, natural laws, and natural phenomena ineligible for patent protection.

View the full Press Release

AMP Opposes Exclusive Licensing of NIH Proteomics Patent

November 2011: AMP Responds to the NIH on the proposal to exclusively license the subject matter of a cancer-related proteonomics patent application filed by the Agency titled "Prospective Grant of Exclusive License: The Development of a Companion
Diagnostic Kit for Predicting Therapeutic Efficacy of Anti-Cancer Agents."
View the full Press Release

AMP 2012 Annual Meeting Call For Session Topics

The AMP Program Committee would like your suggestions for potential program topics for the AMP 2012 Annual Meeting, to be held October 25-27, 2012, at the Long Beach Convention & Entertainment Center, in Long Beach, CA. Deadline to submit is December 31, 2011.

Submit your session topics now.

Current Issue of the AMP Newsletter

Read the October 2011 Newsletter - includes reports from Committees, Subdivisions, Interest & Working Groups; Meritorious Serivce Awards; Annual Meeting: What's New this year & the final Program. Read Past AMP Newsletters.

AMP Responds to Proposed HHS Human Research Protections Rule

October 2011: AMP submits comments to the HHS on the advanced notice of proposed rulemaking (ANPRM) titled, "Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators."
View Comments to HHS (PDF)

AMP Mourns the Loss of Dr. William A. Gardner

Read the notice by AMP Executive Officer Emeritus, Dr. Mark Sobel (PDF)

AMP Urges Congress to Maintain Funding for Graduate Medical Education

September 20, 2011: AMP urged the Joint Select Committee on Deficit Reduction to explore fiscally responsible ways to sustain funding for graduate medical education (GME) and opposed any cuts to this vital funding...Read the letter (PDF)

AMP Responds to FDA RUO/IUO FAQ's

August 30, 2011 (Bethesda, MD): The Association for Molecular Pathology (AMP) submitted comments to the US Food and Drug Administration on the draft guidance document titled, “Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions.”

View the full Press Release (PDF) View Comments to the FDA (PDF)

Divided Appeals Court Rules that Breast Cancer Genes May be Patented but Invalidates Methods Patents

In a 2-1 decision, a federal appeals court today partially reversed a lower court’s ruling in AMP’s case that challenges patents on two human genes associated with hereditary breast and ovarian cancer. Read the Ruling (PDF). View the full Press Release (PDF).

AMP Appoints Mary Steele Williams to Position of Executive Director

Bethesda, MD (June 30, 2011): The Association for Molecular Pathology (AMP) has appointed Mary Steele Williams, MNA, MT(ASCP)SM to the position of Executive Director. This move is indicative of the tremendous growth experienced by the 17 year-old Association. The outgoing Executive Officer, Mark E. Sobel, MD, PhD, a founding member and past President, served for ten years as AMP’s part time Executive Officer and steered it to its current prominence as the voice of molecular pathology. View the full Press Release (PDF).

AMP Opposes Wasserman-Schultz Gene Patent Amendments

AMP and other pathology organizations send letter to the House Judiciary Committee opposing an amendment that includes significant restrictions that would prevent many patients and their physicians from obtaining independent second opinions to confirm initial diagnostic information. Read the Letter to the House Judiciary Committee (PDF)

AMP Comments at FDA Meeting on Next Generation Sequencing

June 23, 2011 (Bethesda, MD): Today, on behalf of the Association for Molecular Pathology (AMP), Dr. Elaine Lyon gave public comments at the US Food and Drug Administration's (FDA) meeting on "Ultra High Throughput Sequencing for Clinical Diagnostic Applications - Approaches to Assess Analytical Validity." As they begin developing their program to evaluate sequencing based diagnostics, AMP advised FDA officials on many important considerations for evaluating analytical validity.

View full Press Release (PDF). View Comments to the FDA (PDF).

June 2011 Issue of the AMP Newsletter

Read the June 2011 Newsletter - Includes reports from Committees, The Journal of Molecular Diagnostics report, the Web Editorial Board, and the AMP 2011 Leadership Award.

AMP Releases Statement on Diagnostics in Drug Labels

May 16, 2011: At a meeting with the Food and Drug Administration, the Association for Molecular Pathology (AMP) released its new position statement on reference to diagnostic tests in drug labels. AMP's statement outlines the organization's commitment to providing high quality medical care and ensuring patients have access to the most appropriate diagnostic tests based on their clinical presentation. View full Press Release (PDF).

JMD Online Access - Login Required

AMP members receive full access to all content published online by The Journal of Molecular Diagnostics. This includes full text of final published articles, Articles-in-Press, and online-only supplements. Login is required to access this content. View login instructions. (PDF)

AMP will Engage NCCN Regarding Molecular Tests

A panel at the recent annual conference of the National Comprehensive Cancer Network (NCCN) called for higher standards in regulating how and where molecular genetics tests are done, better data to determine their value and cost effectiveness, and new approaches to determining their optimal uses for today’s patient populations during a session focused on the implications of molecular testing on practice and policy. Despite being described as an “expert panel,” the panel did not include a molecular pathology professional. A few comments that described the field as juvenile or immature were quite concerning, especially as reported in several rather sensational online articles. Some of the issues discussed are genuine issues, e.g., the need for clarity regarding reimbursement, and are being addressed by the relevant AMP committees. Molecular testing is an active area of discussion at policy tables and AMP is working diligently to ensure that molecular pathology experts, i.e., AMP members, are at those tables. The AMP Professional Relations Committee, with input from the Economic Affairs Committee, will engage the NCCN. See the NCCN report of the panel discussion at http://www.nccn.org/about/news/newsinfo.asp?NewsID=276.

Oral Argument in Gene Patent Case

April 4, 2011: Myriad, ACLU, and the Office of the Solicitor General of the U.S. convened at the U.S. Court of Appeals for the oral argument in AMP et al vs. the USPTO, Myriad Genetics, Inc., et al. An audio recording of the argument is available online. (Search for Appeal Number 2010-1406).

AMA Releases a New Coding System for Molecular Pathology

March 10, 2011: AMA CPT Panel released the outline of a new coding system for molecular pathology assays in genetics, oncology and histocompatibility. The system is based on the EAC White Paper: Proposal for CPT Coding Reform for Molecular Diagnostics.

February 2011 Issue of the AMP Newsletter

Read the February 2011 Newsletter - Includes Subdivision and Committee Reports, New Mode of Publishing The Journal of Molecular Diagnostics (JMD), JMD CME/SAM 2011 Program, 2010 Annual Meeting Photo Album, and Photo Contest Winners, and Young Investigator, Technologist, and Technologist Travel Awardees.

AMP moves to Managed Publishing for JMD

January, 2011: Read the Elsevier Journal Transition Information

AMP Comments to FDA Regarding Draft Guidance on Detection of C. difficile

February 28, 2011: Download the statement

October 2010 Issue of the AMP Newsletter

Read the October 2010 Newsletter  - Includes Subdivision and Committee Reports, the International Affairs Working Group Report, new publishing practices for JMD in 2011, the AMP 2010 Award For Excellence in Molecular Diagnostics and the AMP 2010 Leadership Awards announcements.

Lab Coalition Sends Second Letter to FDA Regarding LDTs

October 6, 2010: Letter notes significant concerns with potential requirement for clinical labs to register as medical device manufacturers. Download the Letter

AMP Commends the SACGHS on a Job Well Done and Provides Comments Regarding Whole Genome Sequencing

October 5, 2010: Dowload the statement

Lab Coalition Encourages FDA to Continue Interaction Regarding Oversight of LDTs

September 15, 2010: AMP joins with other laboratory medicine groups to encourage FDA to continue to interact with our community of organizations "to explore and seek solutions that will not disrupt innovation and the value laboratory developed tests (LDTs) bring to patient care.Download Letter

Archived NEWS..

.